APA (7th ed.) Citation

S, E., J, G., KM, Z., BM, A., Z, L., & A, G. (2019). Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins Syndrome. Pharmaceutical research, 36(9), 137. https://doi.org/10.1007/s11095-019-2671-y

Chicago Style (17th ed.) Citation

S, Ekins, Gerlach J, Zorn KM, Antonio BM, Lin Z, and Gerlach A. "Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins Syndrome." Pharmaceutical Research 36, no. 9 (2019): 137. https://doi.org/10.1007/s11095-019-2671-y.

MLA (9th ed.) Citation

S, Ekins, et al. "Repurposing Approved Drugs as Inhibitors of Kv7.1 and Nav1.8 to Treat Pitt Hopkins Syndrome." Pharmaceutical Research, vol. 36, no. 9, 2019, p. 137, https://doi.org/10.1007/s11095-019-2671-y.